Biomarkers: Tool to identify the Women at increased stroke risk

The Women's Health Initiative hormone trials identified a 44% increase in ischemic stroke risk with combination estrogen plus progestin and a 39% increase with estrogen alone. We undertook a case-control biomarker study to elucidate underlying mechanisms, and to potentially identify women who would be at lower or higher risk for stroke with postmenopausal hormone therapy (HT).

 

  • Applications by Ovulation kits & Fertility Monitors

Related Conference of Biomarkers: Tool to identify the Women at increased stroke risk

September 25-26, 2019

18th World Congress on Nutrition and Food Chemistry

Copenhagen, Denmark
November 14-15, 2019

21st International Congress on Nutrition & Health

Zagreb, Croatia
November 14-15, 2019,

2nd Annual Meeting on Nutrition & Dietetics

Zagreb | Croatia
February 12-13, 2020

31st World Congress on Nutrition & Food Sciences

Auckland, New Zealand
February 24-25, 2020

23rd World Congress on Nutrition and Food Sciences

Tokyo, Japan
March 26-27, 2020

24th Asia Pacific
Nutrition Meet and Expo

Kyoto, Japan
April 13-14, 2020

31st Annual Congress on Nutrition & Food Sciences

Bangkok, Thailand
April 20-21, 2020

26th European Nutrition and Dietetics Conference

Berlin, Germany

Biomarkers: Tool to identify the Women at increased stroke risk Conference Speakers

Recommended Sessions

Related Journals

Are you interested in